NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 82 filers reported holding NATERA INC in Q2 2017. The put-call ratio across all filers is 25.33 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $951,862 | +338.5% | 21,511 | +382.2% | 0.00% | – |
Q2 2023 | $217,072 | -12.3% | 4,461 | +0.0% | 0.00% | – |
Q1 2023 | $247,564 | -94.3% | 4,459 | -89.5% | 0.00% | -100.0% |
Q1 2021 | $4,308,000 | -3.8% | 42,423 | -5.7% | 0.00% | 0.0% |
Q4 2020 | $4,479,000 | +51.8% | 45,008 | +10.2% | 0.00% | +33.3% |
Q3 2020 | $2,951,000 | +48.7% | 40,851 | -1.8% | 0.00% | +50.0% |
Q2 2020 | $1,984,000 | +66.7% | 41,586 | +4.3% | 0.00% | +100.0% |
Q1 2020 | $1,190,000 | +4.2% | 39,856 | +17.6% | 0.00% | 0.0% |
Q4 2019 | $1,142,000 | +0.9% | 33,893 | -3.7% | 0.00% | 0.0% |
Q3 2019 | $1,132,000 | +17.1% | 35,197 | +0.4% | 0.00% | 0.0% |
Q2 2019 | $967,000 | +104.0% | 35,070 | +52.7% | 0.00% | 0.0% |
Q1 2019 | $474,000 | +222.4% | 22,965 | +118.8% | 0.00% | – |
Q4 2018 | $147,000 | -72.5% | 10,496 | -53.1% | 0.00% | -100.0% |
Q3 2018 | $535,000 | +16.8% | 22,357 | -8.1% | 0.00% | 0.0% |
Q2 2018 | $458,000 | +90.0% | 24,322 | -6.2% | 0.00% | – |
Q1 2018 | $241,000 | +1.3% | 25,930 | -2.0% | 0.00% | – |
Q4 2017 | $238,000 | -28.5% | 26,455 | +2.4% | 0.00% | – |
Q3 2017 | $333,000 | +14.4% | 25,837 | -3.7% | 0.00% | – |
Q2 2017 | $291,000 | +50.0% | 26,826 | +23.3% | 0.00% | – |
Q1 2017 | $194,000 | -14.5% | 21,753 | +12.2% | 0.00% | – |
Q4 2016 | $227,000 | +4.6% | 19,391 | -0.6% | 0.00% | – |
Q3 2016 | $217,000 | -5.7% | 19,499 | +2.2% | 0.00% | – |
Q2 2016 | $230,000 | +641.9% | 19,081 | +491.5% | 0.00% | – |
Q1 2016 | $31,000 | +933.3% | 3,226 | +1244.2% | 0.00% | – |
Q4 2015 | $3,000 | 0.0% | 240 | 0.0% | 0.00% | – |
Q3 2015 | $3,000 | – | 240 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |